Adverum Biotechnologies, Inc. Common Stock

ADVM US00773U1088

💰
Capitalization
Small-cap

Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) injections. It has one segment developing and commercializing gene therapeutics.

🔗
Website
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
25
🙍
Insiders
6
Person Price Shares Total Published Completed
Fischer Laurent
CEO 		2.00
USD 		9,126
Sold 		18,252
USD 		15/05/2025 15/05/2025
Fischer Laurent
CEO 		2.00
USD 		9,126
Sold 		18,252
USD 		15/05/2025 15/05/2025
Seyedkazemi Setareh
EX OFF 		2.00
USD 		924
Sold 		1,848
USD 		15/05/2025 15/05/2025
Soparkar Peter
COO 		2.00
USD 		2,960
Sold 		5,920
USD 		15/05/2025 15/05/2025
Fischer Laurent
CEO 		2.00
USD 		9,126
Sold 		18,252
USD 		15/05/2025 15/05/2025
Leonard Braden Michael
 2.98
USD 		50,000
Bought 		148,950
USD 		22/04/2025 23/04/2025
Leonard Braden Michael
 3.00
USD 		300,000
Bought 		900,000
USD 		22/04/2025 22/04/2025
Leonard Braden Michael
 4.04
USD 		15,209
Bought 		61,408
USD 		31/03/2025 02/04/2025
Leonard Braden Michael
 4.38
USD 		19,566
Bought 		85,668
USD 		31/03/2025 31/03/2025
Leonard Braden Michael
 5.19
USD 		16,593
Bought 		86,089
USD 		26/03/2025 27/03/2025

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Adverum Biotechnologies, Inc. Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Last 52W Low 52W High All-Time Low All-Time High β
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Leonard Braden Michael 18 5,999,680.68 333,315.59 17/07/2024 23/04/2025
Lupher, Jr. Mark L. 1 175,500.00 175,500.00 07/02/2024 07/02/2024
Scopa James Paul 1 135,000.00 135,000.00 07/02/2024 07/02/2024
Fischer Laurent 3 54,756.00 18,252.00 15/05/2025 15/05/2025
Soparkar Peter 1 5,920.00 5,920.00 15/05/2025 15/05/2025
Seyedkazemi Setareh 1 1,848.00 1,848.00 15/05/2025 15/05/2025

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.